(TORONTO: December 4, 2008) - An Ontario study of 491 women with invasive ovarian cancer found only a small proportion, 19%, were referred for genetic testing of BRCA1 and BRCA2, the breast cancer genes, which means family members are not informed of their cancer risk.
Dr. Kelly Metcalfe, an associate professor at the University of Toronto's Lawrence S. Bloomberg Faculty of Nursing, and an adjunct scientist at Women's College Research Institute, led the nursing study, which was published online yesterday in the journal, Gynecologic Oncology.